Mérieux Développement leads $21 mln Series B funding in ImaginAb
Mérieux Développement has led a $21 million Series B funding round in ImaginAb Inc., a clinical stage biotech company. The funding was syndicated with Novartis Venture Funds, Cycad Group and Nextech Invest.
9 May 2014•4 mins read
